The STEP (Semaglutide Treatment Effect in People with Obesity) trials represent the most comprehensive safety data available for semaglutide at the 2.4 mg weight loss dose
This dual-action approach makes it the first medication of its kind, often leading to even more significant weight loss results
However, as with all prescribed medications, GLP-1 and GIP weight loss medications must be supervised by a doctor
Regulatory Note: Compounded semaglutide and tirzepatide are not FDA-approved and are not generic versions of Ozempic, Wegovy, or Mounjaro.
Our Customers Rave about our Vitamin IV THERAPY IV THERAPY NEAR ME What our clients have to say about our staff, service and proprietary cocktails
For normalization of the assay results, the erythrocyte lysate was analyzed for HGB concentration using an automated analyzer (Celltac- MEK 6450, Nihon Kohden, Qinlab Diagnostik, Weichs, Germany)